Article: Technitrol Completes Divestiture of Medtech Components Business.

Technitrol, Inc. (NYSE: TNL) announced that the company has completed the previously announced sale of its Medtech components business ("Medtech") to Altor Fund III ("Altor"). The sale price was approximately $200 million in cash. Medtech includes the former Sonion A/S's balanced armature receivers, high-end microphones and electromechanical devices for the hearing aid, high-end audio headset and medical device markets. Remaining with Technitrol will be the former Sonion business engaged in high-volume transducers mainly for speakers used in cell phones and similar communication devices.

Net proceeds from the divestiture are being applied to reduce Technitrol's ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!